•
Novo Nordisk (CPH: NOVO-B), a Danish pharmaceutical giant, has reached an agreement to acquire a production facility in Ireland from Alkermes (NASDAQ: ALKS), a drug manufacturer, along with related assets for a total consideration of USD 92.5 million. The transaction, which is subject to customary adjustments and fulfillment of closing…